Article-Journal

Mapping Bone Marrow Response in the Vertebral Column by Positron Emission Tomography Following Radiotherapy and Erlotinib Therapy of Lung Cancer

To map functional bone marrow (BM) by 2-deoxy-2-[¹⁸F]fluoro-D-glucose ([¹⁸F]FDG) positron emission tomography (PET) in the vertebral …

Azadeh Abravan, Hanne Astrid Eide, Ayca Muftuler Løndalen, Åslaug Helland, Eirik Malinen

Apr 1, 2019

Ocular signatures of proactive versus reactive cognitive control in young adults

During the execution of a cognitive task, the brain maintains contextual information to guide behavior and achieve desired goals. The …

Verónica Mäki-Marttunen, Thomas Hagen, Samira Aminihajibashi, Maja Foldal, Maria Stavrinou, Jens H Halvorsen, Bruno Laeng, Thomas Espeseth

Oct 1, 2018

Osteonecrosis of the Jaw in a Patient With Bone Metastatic Prostate Cancer After Long-term Bisphosphonate Treatment With Severe Deterioration Following Radium-223

No abstract available

Bente Brokstad Herlofson, Gry Karina Kjølle, Kristine Løken Westgaard, Ayca M Løndalen, Øyvind S Bruland

Oct 1, 2018

Low dose-rate irradiation with [3H]-labelled valine to selectively target hypoxic cells in a human colorectal cancer xenograft model

Earlier in vitro studies show that irradiation with an ultra-low dose-rate of 15 mGy/h delivered with [³H]-valine leads to loss of …

Stine Gyland Mikalsen, Lars Tore Gyland Mikalsen, Joe Alexander Sandvik, Eva-Katrine Aarnes, Siri Fenne, Kjersti Flatmark, Heidi Lyng, Nina Frederike Jeppesen Edin, Erik Olai Pettersen

Sep 1, 2018

The Effect of New Formulas for Lean Body Mass on Lean-Body-Mass-Normalized SUV in Oncologic 18F-FDG PET/CT

Because of better precision and intercompatibility, the use of lean body mass (LBM) as a mass estimate in the calculation of SUV (SUL) …

Trygve Halsne, Ebba Glørsen Müller, Ann-Eli Spiten, Alexander Gul Sherwani, Lars Tore Gyland Mikalsen, Mona-Elisabeth Revheim, Caroline Stokke

Sep 1, 2018

Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients

¹⁷⁷Lu-lilotomab satetraxetan is a novel anti-CD37 antibody radionuclide conjugate for the treatment of non-Hodgkin lymphoma (NHL). Four …

Caroline Stokke, Johan Blakkisrud, Ayca Løndalen, Jostein Dahle, Anne C T Martinsen, Harald Holte, Arne Kolstad

Jul 1, 2018

Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan

¹⁷⁷Lu-lilotomab satetraxetan is a novel antibody-radionuclide conjugate currently in a phase 1/2a first-in-humans dose escalation trial …

Johan Blakkisrud, Jon Erik Holtedahl, Ayca Løndalen, Jostein Dahle, Tore Bach-Gansmo, Harald Holte, Stine Nygaard, Arne Kolstad, Caroline Stokke

Apr 1, 2018

Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy

Radiation therapy effectively kills cancer cells and elicits local effects in the irradiated tissue. The aim of this study was to …

Hanne a Eide, Ingerid Skjei Knudtsen, Vandana Sandhu, Ayca M Løndalen, Ann Rita Halvorsen, Azadeh Abravan, Elin H Kure, Trond v Bogsrud, Odd Terje Brustugun, Jon Amund Kyte, Eirik Malinen, Åslaug Helland

Feb 13, 2018

Respiratory motion during 90Yttrium PET contributes to underestimation of tumor dose and overestimation of normal liver tissue dose

Background Yttrium-90 dosimetry after radioembolization is reliant on accurate quantitative imaging of the microsphere deposition. …

Line Ausland, Mona-Elisabeth Revheim, Arne Skretting, Caroline Stokke

Feb 1, 2018